Search Results for "poverty guidelines"
Displaying 1 - 10 of 10 results. 20 results shown per page. Page 1 of 1.
CMS — SafeBlood: Request for Correction (RFC)
Publication Date
November 14, 2002. BEFORE THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICESCENTERS FOR MEDICARE AND MEDICAID SERVICES INFORMATION QUALITY REQUEST FOR CORRECTION OF CERTAINDISSEMINATED INFORMATION
Analytical Framework for Examining the Value of Antibacterial Products
Publication Date
By: Aylin Sertkaya, John Eyraud, Anna Birkenbach, Calvin Franz, Nyssa Ackerley, Valerie Overton, Kevin Outterson Abstract
Examination of Clinical Trial Costs and Barriers for Drug Development
Publication Date
TASK ORDER NO. HHSP23337007T CONTRACT NO. HHSP23320095634WC
CMS — SafeBlood: Interim Response, January 14, 2003
Publication Date
January 14, 2003 Debby Thetford Nye, Esq. Mitchell, Williams, Selig, Gates, and Woodward, P.L.L.C. 5414 Pinnacle Point Drive, Suite 500 Rogers, Arkansas 72758-8131 Dear Ms. Nye:
Health Care in Transition: Technology Assessment in the Private Sector
Publication Date
Health Care in Transition: Technology Assessment in the Private Sector Prepared by: Richard Rettig of the RAND Corporation Office of the Assistant Secretary of Planning and Evaluation Agency for Health Care Policy and Research. July, 1996.
Health Care in Transition: Technology Assessment in the Private Sector
Publication Date
Health Care in Transition: Technology Assessment in the Private Sector Medical technology, broadly construed, embraces innovations in medicine--new drugs, biologics, medical devices, and procedures--as well as existing therapeutic and diagnostic capabilities.
CMS — Safeblood: HHS Response to Rfc
Publication Date
April 17, 2003 Debbie Thetford Nye Mitchell, Williams, Selig, Gates, and Woodward, P.L.L.C. 5414 Pinnacle Point Drive, Suite 500 Rogers, Arkansas 72758-8131 Dear Ms. Nye:
Cost Effectiveness Considerations in the Approval and Adoption of New Health Technologies
Publication Date
Contents Background and Purpose Methodology Summary of Key Findings and Stakeholder Suggestions Conclusions and Policy Implications A.
CMS — SafeBlood: Interim Response, February 13, 2003
Publication Date
February 13, 2003 Debby Thetford Nye, Esq. Mitchell, Williams, Selig, Gates, and Woodward, P.L.L.C. 5414 Pinnacle Point Drive, Suite 500 Rogers, Arkansas 72758-8131 Dear Ms. Nye:
Economic Analysis of Availability of Follow-on Protein Products
Publication Date
Contract HHSP23320045017XI Task Order HHSP233200700003T Prepared for: Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation Prepared by: